PRKAA2 and metabolic dysfunction-associated steatotic liver disease: These findings support the role of AMPK suppression in promoting lipogenesis, insulin resistance, hepatic steatosis, and NAFLD (21, 81–84), highlighting the importance of AMPK/ACC signaling in metabolic regulation.